Further Investigation of an Intramuscular Influenza Vaccine (Multimeric-001)

NCT01146119 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Multimeric-001, 500 mcg
BIOLOGICAL: Adjuvanted PBS
BIOLOGICAL: PBS and TIV 15%
BIOLOGICAL: PBS and TIV 50%

Sponsor

BiondVax Pharmaceuticals ltd.